What Companies Are In The VanEck Semiconductor ETF?
There’s a lot to love about the VanEck Semiconductor ETF,…
Sell
20
PRTC Quote, Financials, Valuation and Earnings
Last price:
$18.85
Seasonality move
:
-6.06%
Day range:
$18.80 - $18.80
52-week range:
$18.19 - $34.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
300.98x
P/B ratio:
1.43x
Volume:
351
Avg. volume:
4.8K
1-year change:
-24.8%
Market cap:
$450.1M
Revenue:
$750K
EPS (TTM):
-$3.00
Analysts' Opinion
-
Consensus RatingPureTech Health PLC has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $53.25, PureTech Health PLC has an estimated upside of 183.25% from its current price of $18.80.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $46.00 representing 100% downside risk from its current price of $18.80.
Fair Value
-
According to the consensus of 2 analysts, PureTech Health PLC has 183.25% upside to fair value with a price target of $53.25 per share.
PRTC vs. S&P 500
-
Over the past 5 trading days, PureTech Health PLC has underperformed the S&P 500 by -3.92% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
PureTech Health PLC does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
PureTech Health PLC has grown year-over-year revenues for 0 quarters straight. In the most recent quarter PureTech Health PLC reported revenues of --.
Earnings Growth
-
PureTech Health PLC has grown year-over-year earnings for 0 quarters straight. In the most recent quarter PureTech Health PLC reported earnings per share of --.
Enterprise value:
-57.6M
EV / Invested capital:
--
Price / LTM sales:
300.98x
EV / EBIT:
--
EV / Revenue:
-33.89x
PEG ratio (5yr expected):
--
EV / Free cash flow:
0.48x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-05 | 2024-01-05 | 2024-01-05 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $346.9M | $451.1M | $381.8M | $360.1M | $508.8M | |
| Total Assets | $1.1B | $896.9M | $823.2M | $693.6M | $580M | |
| Current Liabilities | $156M | $213.9M | $150.3M | $49.3M | $138.3M | |
| Total Liabilities | $338.6M | $335.5M | $247.1M | $184.7M | $273.7M | |
| Total Equity | $766.9M | $561.4M | $576M | $508.9M | $306.2M | |
| Total Debt | $1.5M | $43.7M | $16.8M | $2.4M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-05 | 2024-01-05 | 2024-01-05 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
PRTC
Sector
Market Cap
$450.1M
$49.2M
Price % of 52-Week High
55.29%
48.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-24.8%
-30.94%
Beta (5-Year)
--
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$19.34
200-day SMA
Sell
Level
$23.73
Bollinger Bands (100)
Sell
Level
19.77 - 22.27
Chaikin Money Flow
Sell
Level
-308.5K
20-day SMA
Sell
Level
$20.62
Relative Strength Index (RSI14)
Sell
Level
38.90
ADX Line
Sell
Level
39.45
Williams %R
Buy
Level
-88.1783
50-day SMA
Sell
Level
$21.10
MACD (12, 26)
Sell
Level
-0.69
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
225.6K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.524)
Buy
CA Score
(Annual)
Level (0.4009)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-0.4)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Stock Forecast FAQ
In the current month, PRTC has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The PRTC average analyst price target in the past 3 months is $53.25.
-
Where Will PureTech Health PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that PureTech Health PLC share price will rise to $53.25 per share over the next 12 months.
-
What Do Analysts Say About PureTech Health PLC?
Analysts are divided on their view about PureTech Health PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that PureTech Health PLC is a Sell and believe this share price will drop from its current level to $46.00.
-
What Is PureTech Health PLC's Price Target?
The price target for PureTech Health PLC over the next 1-year time period is forecast to be $53.25 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is PRTC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for PureTech Health PLC is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PRTC?
You can purchase shares of PureTech Health PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase PureTech Health PLC shares.
-
What Is The PureTech Health PLC Share Price Today?
PureTech Health PLC was last trading at $18.85 per share. This represents the most recent stock quote for PureTech Health PLC. Yesterday, PureTech Health PLC closed at $18.80 per share.
-
How To Buy PureTech Health PLC Stock Online?
In order to purchase PureTech Health PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Can Palantir Stock Go?
Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…
Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
39
DOGZ alert for Jan 4
Dogness (International) [DOGZ] is down 20.52% over the past day.
Buy
66
DMRC alert for Jan 4
Digimarc [DMRC] is up 16.19% over the past day.
Sell
39
MSTR alert for Jan 4
MicroStrategy [MSTR] is up 13.33% over the past day.
